This is the supplier profile page of Wuxi Hongrui Biopharma Tech Co., Ltd., where buyers can explore products, connect directly with the supplier for pricing inquiries.
China
0
14-302 Lihu Garden, 1800 Lihu Avenue
Add Favorite
Report Supplier
Business Description
Wuxi Hongrui BioPharmaTech Co., Ltd (HRBPT) is a private corporation focused on the manufacturing of ester derivatives of L-ascorbic acid catalyzed by lipase in organic media, and the extracting of natural bioactive products, such as gossypol, allicin,alliin,garlic oil blend.HRBPT was established in February 21, 2010,is Wuxi 530 enterprises (the second batch of C in 2009),high tech private enterprises in Jiangsu Province.The founder was the leader of the returnees,Professor Tang LuHong, director of biocatalysis and biochemical separation pharmaceutical research laboratory, School of pharmacy, Jiangnan University.More than 5 years of overseas study and work experience,was a professor at the Commonwealth University, a member of the academic committee, and a technical director of a Singapore listed company.We have established the world's first vacuum discontinuous azeotropic water removal coupled simulation mobile platform for continuous separation of esterase producing zero emission technology platform.The enzyme (clean) production of L- ascorbic acid fatty acid ester series, pharmaceutical excipients Tween/Span series, biodiesel and a large number of ester products has been successfully realized.L- ascorbic acid ibuprofen ester, 3- palmitic shikimic acid and other new monomers were synthesized.We discovered the activity of gossypol against schistosomiasis and found a new specific therapeutic agent for schistosomiasis.The resource utilization of garlic wastewater has been realized and the worldwide problem has been solved.We have developed a series of substitutes for concentrated garlic based feed antibiotics, and provided a new solution for meat and egg products to achieve no antibiotic.More than 30 patents have been applied, of which 12 (including 2 US patents) have been authorized.We applied and held 11 trademarks, such as QianRuiSi, LuHong and HongJiRuiYe.More than 20 articles and 8 SCI articles are published.Under the leading of international recognized exports in the field of bio-catalyzed synthesis, developing and applying of oil soluble antioxidant and supermolecular aggregates based on L-ascorbyl-6-O-palmitate, HRBPT is proud to possess the top level R&D team, facility and the capability to deliver the R&D service and product value-added service.Insists on the idea that In order to improve the LIFE QUALITY and the QUALITY OF LIFE together, our material need should be met in Sustainable & Environmental Benign Way, and we can, Hongrui BPT commit itself to manufacture the fine chemicals, including the chiral medicines, in the environmentally benign way. As a result of such efforts, an enzymatic processing has been established for the production of esters cleanly, such as L-ascorbyl palmitate (L-AP), L-ascorbyl-(S)-ibuprofenate (L-AI), Tween 2080 and Span 2080, as well as monopalmityloxy shikimic acid (MPSA).Consumption of bio-synthesized L-AP as well as other products, will Not Only Be Helpful for your health, But Also Be Helpful for the effective reduction of pollution.Looking forward to your participation and cooperation.Sincerely wish you could benefit from our efforts, services and products.
Export Capabilities
Declared by supplierWuxi Hongrui Biopharma Tech Co., Ltd. has been exporting since 2010.
Export start year
2010
Trade Capabilities
Business Terms
Trade Ability
